Financials OmniAb, Inc.

Equities

OABI

US68218J1034

Biotechnology & Medical Research

Market Closed - Nasdaq 21:00:00 25/06/2024 BST 5-day change 1st Jan Change
3.79 USD -6.65% Intraday chart for OmniAb, Inc. -9.55% -38.57%

Valuation

Fiscal Period: December 2022 2023 2024 2025 2026
Capitalization 1 413.4 717.6 445.8 - -
Enterprise Value (EV) 1 325.1 717.6 445.8 445.8 445.8
P/E ratio -13.8 x -12.1 x -6 x -8.9 x -13.3 x
Yield - - - - -
Capitalization / Revenue 7 x 21 x 15.2 x 8.02 x 5.88 x
EV / Revenue 7 x 21 x 15.2 x 8.02 x 5.88 x
EV / EBITDA -30.4 x -12.8 x -7.68 x -12.8 x -43.7 x
EV / FCF -19.9 x -17.7 x -9.8 x -12.3 x 137 x
FCF Yield -5.02% -5.64% -10.2% -8.1% 0.73%
Price to Book 1.22 x - - - -
Nbr of stocks (in thousands) 114,821 116,301 117,615 - -
Reference price 2 3.600 6.170 3.790 3.790 3.790
Announcement Date 30/03/23 20/03/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2022 2023 2024 2025 2026
Net sales 1 59.08 34.16 29.32 55.61 75.85
EBITDA 1 -13.6 -55.86 -58.04 -34.89 -10.2
EBIT 1 -26.65 -69.42 -79.59 -51.76 -32.08
Operating Margin -45.11% -203.19% -271.45% -93.06% -42.3%
Earnings before Tax (EBT) 1 -26.06 -64.36 -75.92 -49.02 -34.11
Net income 1 -22.33 -50.62 -66.51 -46.24 -31.26
Net margin -37.8% -148.16% -226.82% -83.14% -41.21%
EPS 2 -0.2600 -0.5100 -0.6312 -0.4257 -0.2850
Free Cash Flow 1 -20.76 -40.44 -45.48 -36.12 3.263
FCF margin -35.13% -118.37% -155.1% -64.95% 4.3%
FCF Conversion (EBITDA) - - - - -
FCF Conversion (Net income) - - - - -
Dividend per Share - - - - -
Announcement Date 30/03/23 20/03/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2
Net sales 1 6.91 35.34 16.92 6.946 5.477 4.822 3.801 5.765 8.361 11.39 9.619 10.08
EBITDA 1 - - -5.084 -16.06 -16.92 -17.8 -17.6 -17.67 -13.54 -9.226 -12.9 -12.73
EBIT 1 - 9.05 -8.453 -19.44 -20.32 -21.21 -22.55 -22.07 -19.63 -17.26 -17.83 -17.65
Operating Margin - 25.6% -49.96% -279.95% -370.91% -439.78% -593.34% -382.79% -234.75% -151.61% -185.35% -175.08%
Earnings before Tax (EBT) 1 - 9.637 -7.129 -18.16 -19.04 -20.03 -21.58 -20.45 -18.12 -15.69 -12 -12.1
Net income 1 -12.6 6.82 -6.1 -14.73 -15.74 -14.05 -18.96 -18.13 -15.98 -13.43 -12.67 -12.58
Net margin -182.29% 19.3% -36.05% -212.04% -287.35% -291.44% -498.84% -314.55% -191.15% -117.98% -131.72% -124.76%
EPS 2 - 0.0700 -0.0600 -0.1500 -0.1600 -0.1400 -0.1900 -0.1712 -0.1488 -0.1250 -0.1400 -0.1400
Dividend per Share - - - - - - - - - - - -
Announcement Date 14/11/22 30/03/23 11/05/23 10/08/23 09/11/23 20/03/24 09/05/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2022 2023 2024 2025 2026
Net Debt - - - - -
Net Cash position 88.3 - - - -
Leverage (Debt/EBITDA) - - - - -
Free Cash Flow 1 -20.8 -40.4 -45.5 -36.1 3.26
ROE (net income / shareholders' equity) -7.76% - - - -
ROA (Net income/ Total Assets) - - - - -
Assets 1 - - - - -
Book Value Per Share 2.960 - - - -
Cash Flow per Share 2 -0.0400 -0.2300 -0.3100 - -
Capex 1 17.2 1.64 5 5 5.25
Capex / Sales 29.06% 4.81% 17.05% 8.99% 6.92%
Announcement Date 30/03/23 20/03/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
3.79 USD
Average target price
9.875 USD
Spread / Average Target
+160.55%
Consensus
  1. Stock Market
  2. Equities
  3. OABI Stock
  4. Financials OmniAb, Inc.